4/22
07:59 pm
amgn
Why Amgen (AMGN) Outpaced the Stock Market Today [Yahoo! Finance]
Low
Report
Why Amgen (AMGN) Outpaced the Stock Market Today [Yahoo! Finance]
4/18
12:50 pm
amgn
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects [Yahoo! Finance]
Low
Report
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects [Yahoo! Finance]
4/18
08:04 am
amgn
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at UBS Group AG from $314.00 to $284.00. They now have a "neutral" rating on the stock.
Low
Report
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at UBS Group AG from $314.00 to $284.00. They now have a "neutral" rating on the stock.
4/17
07:39 pm
amgn
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights [Yahoo! Finance]
Low
Report
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights [Yahoo! Finance]
4/17
03:26 pm
amgn
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at TD Cowen from $370.00 to $360.00. They now have a "buy" rating on the stock.
Low
Report
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at TD Cowen from $370.00 to $360.00. They now have a "buy" rating on the stock.
4/17
07:43 am
amgn
Can This High-Yield Dividend Stock Keep Beating the S&P 500? [Yahoo! Finance]
Low
Report
Can This High-Yield Dividend Stock Keep Beating the S&P 500? [Yahoo! Finance]
4/16
05:32 pm
amgn
AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024 [Yahoo! Finance]
Low
Report
AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024 [Yahoo! Finance]
4/16
05:26 pm
amgn
AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
Low
Report
AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
4/16
11:31 am
amgn
Global Surgical Suture Market Set to Reach US$ 7,170.1 Million by 2034, Fueled by Technological Advancements and Growing Preference for Sutures Over Alternatives | FMI [Yahoo! Finance]
Low
Report
Global Surgical Suture Market Set to Reach US$ 7,170.1 Million by 2034, Fueled by Technological Advancements and Growing Preference for Sutures Over Alternatives | FMI [Yahoo! Finance]
4/15
04:39 am
amgn
Amgen: The Giant With An Impressive Pipeline [Seeking Alpha]
Low
Report
Amgen: The Giant With An Impressive Pipeline [Seeking Alpha]
4/13
10:53 am
amgn
AbbVie keeps Humira market share near 100% despite biosimilars: report [Seeking Alpha]
Low
Report
AbbVie keeps Humira market share near 100% despite biosimilars: report [Seeking Alpha]
4/12
12:11 pm
amgn
Amgen Inc. (NASDAQ: AMGN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $320.00 price target on the stock.
Low
Report
Amgen Inc. (NASDAQ: AMGN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $320.00 price target on the stock.
4/11
07:45 pm
amgn
Amgen (AMGN) Laps the Stock Market: Here's Why [Yahoo! Finance]
Low
Report
Amgen (AMGN) Laps the Stock Market: Here's Why [Yahoo! Finance]
4/11
08:06 am
amgn
Is Amgen Stock a Buy? [Yahoo! Finance]
Low
Report
Is Amgen Stock a Buy? [Yahoo! Finance]
4/11
07:22 am
amgn
FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer [Yahoo! Finance]
Low
Report
FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer [Yahoo! Finance]
4/10
08:13 am
amgn
Nodexus Adds Flow Cytometry Leaders to Scientific Advisory Board [Yahoo! Finance]
Low
Report
Nodexus Adds Flow Cytometry Leaders to Scientific Advisory Board [Yahoo! Finance]
4/8
10:42 am
amgn
3 Top Dividend Stocks to Maximize Your Retirement Income [Yahoo! Finance]
Low
Report
3 Top Dividend Stocks to Maximize Your Retirement Income [Yahoo! Finance]
4/5
08:03 pm
amgn
Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note [Yahoo! Finance]
Low
Report
Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note [Yahoo! Finance]
4/4
12:39 pm
amgn
[Latest] Global Bispecific Antibodies Market Size/Share Worth USD 53.8 Billion by 2033 at a 24.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) [Yahoo! Finance]
Low
Report
[Latest] Global Bispecific Antibodies Market Size/Share Worth USD 53.8 Billion by 2033 at a 24.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) [Yahoo! Finance]
4/3
01:21 pm
amgn
Here's Why Amgen (AMGN) Stock is Outperforming the Industry [Yahoo! Finance]
Low
Report
Here's Why Amgen (AMGN) Stock is Outperforming the Industry [Yahoo! Finance]
4/3
09:31 am
amgn
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $329.00 price target on the stock.
Low
Report
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $329.00 price target on the stock.
4/1
07:48 pm
amgn
Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know [Yahoo! Finance]
Low
Report
Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know [Yahoo! Finance]
4/1
08:01 am
amgn
KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer [Yahoo! Finance]
Low
Report
KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer [Yahoo! Finance]
3/31
11:26 am
amgn
Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock [Seeking Alpha]
Low
Report
Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock [Seeking Alpha]
3/28
11:03 pm
amgn
Amgen Inc. (NASDAQ: AMGN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Amgen Inc. (NASDAQ: AMGN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.